Intravenous Phenoxybenzamine Use in Pediatric Patients Undergoing Open-Heart Surgery

• Status: Completed
• Trial end date: 2010-08-01
• Target enrollment: 0
• Participant gender: All

Summary

Cardiopulmonary bypass is done with a machine that does the work of the heart and lungs during open-heart surgery. This study is to determine if intravenous (i.v.) phenoxybenzamine is safe. This drug lowers the blood pressure, making it easier for the cardiopulmonary bypass machine to deliver blood and oxygen to all of the organs and tissues.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Arkansas
• Collaborator: Arkansas Children's Hospital Research Institute
• Treatments: Phenoxybenzamine

Criteria

Inclusion Criteria:

• 0-18 years of age

• weight of less than or equal to 20 kilograms

Exclusion Criteria:

• Parental refusal to give informed consent